Evidence map›Paper›PMID 42625793›Full record

ArticleFrontiers in cellular and infection microbiology2026

Development and validation of a temporal staging-based nomogram for 1-year mortality in sepsis-associated acute kidney injury.

Jingrong Liu, Kaizhen Han, Hui Pei, Luanluan Zhang, Xianfei Ding, Ke Li, Jiafeng Xie, Yahui Huang, Dong Xu, Zhiqiang Zhu and 1 more

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jingrong Liu *Department of Emergency ICU, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China.
Kaizhen Han *Department of Emergency ICU, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China.
Hui PeiDepartment of Emergency ICU, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China.
Luanluan ZhangDepartment of Emergency ICU, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China.
Xianfei DingDepartment of Critical Care Medicine, Department of Emergency Medicine, The First Affiliated Hospital of Zhengzhou University, Henan Engineering Research Center for Critical Care Medicine, Henan Key Laboratory of Critical Care Medicine, Henan Key Laboratory of Sepsis in Health Commission, Zhengzhou Key Laboratory of Sepsis, Henan Sepsis Diagnosis and Treatment Center, Zhengzhou, China.
Ke LiDepartment of Emergency ICU, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China.
Jiafeng XieDepartment of Emergency ICU, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China.
Yahui HuangDepartment of Emergency ICU, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China.
Dong XuDepartment of Emergency ICU, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China.
Zhiqiang ZhuDepartment of Emergency ICU, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China.
Tongwen SunDepartment of Critical Care Medicine, Department of Emergency Medicine, The First Affiliated Hospital of Zhengzhou University, Henan Engineering Research Center for Critical Care Medicine, Henan Key Laboratory of Critical Care Medicine, Henan Key Laboratory of Sepsis in Health Commission, Zhengzhou Key Laboratory of Sepsis, Henan Sepsis Diagnosis and Treatment Center, Zhengzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Sepsis-associated acute kidney injury (SA-AKI) is a life-threatening condition with poor prognosis. However, due to significant inter-individual variability in disease progression, clinicians lack reliable tools to stratify patients based on long-term mortality risk. Objective: This study explores how the timing of SA-AKI (early vs. late onset) affects survival, based on the latest ADQI consensus, and aims to build a simple nomogram to predict 1-year mortality. Methods: A retrospective cohort study enrolled 422 SA-AKI patients (from 3273 sepsis patients) admitted to the First Affiliated Hospital of Zhengzhou University between January 2020 and December 2024. Patients were stratified into early-onset SA-AKI(E-SA-AKI, within 48 hours of sepsis diagnosis) and late-onset SA-AKI (L-SA-AKI, 48 hours-7 days post-sepsis) groups, with a maximum 5-year follow-up. Results: The study found that most SA-AKI cases were early-onset (E-SA-AKI vs. L-SA-AKI: 73% vs. 27%). The median age of patients was 65 years, with 72% males. The primary infection sources were abdominal (41.9%) and pulmonary/urinary (36.3%). The cumulative survival rates at 28 days, 90 days, 1 year, and 5 years were 50.5%, 44.8%, 38.9%, and 33.9%, respectively. Both short-term and long-term survival rates were significantly higher in E-SA-AKI patients than L-SA-AKI patients(all Conclusion: The timing of SA-AKI onset is a critical prognostic stratification indicator. A one-year mortality risk nomogram model constructed based on the temporal staging, septic shock, albumin level, 28-day renal function recovery status, and 48-hour lactate normalization provides important reference for clinical decision-making.

Indexed as

Acute Kidney InjuryNomogramsSepsisAgedFemaleHumansMaleMiddle AgedPrognosisRetrospective StudiesRisk FactorsTime Factorsclinical outcomeslactate normalizationmortalityprognostic factorsepsis-associated acute kidney injurytemporal staging

Identifiers

PMID42625793
PMCPMC13490152

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.